Evidence map›Paper›PMID 24830754›Full record

ArticlePloS one2014

A computerized prediction model of hazardous inflammatory platelet transfusion outcomes.

Kim Anh Nguyen, Hind Hamzeh-Cognasse, Marc Sebban, Elisa Fromont, Patricia Chavarin, Lena Absi, Bruno Pozzetto, Fabrice Cognasse, Olivier Garraud

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Transfusion-Related Acute Lung Injury: from Mechanistic Insights to Therapeutic Strategies.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Platelet Inflammatory Response to Stress.Frontiers in immunology · 2019
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kim Anh NguyenGIMAP-EA3064, Université de Lyon, Saint-Étienne, France.
Hind Hamzeh-CognasseGIMAP-EA3064, Université de Lyon, Saint-Étienne, France.
Marc SebbanLaboratoire Hubert Curien - UMR CNRS 5516, Saint-Etienne, France.
Elisa FromontLaboratoire Hubert Curien - UMR CNRS 5516, Saint-Etienne, France.
Patricia ChavarinEFS Auvergne-Loire, Saint-Etienne, France.
Lena AbsiEFS Auvergne-Loire, Saint-Etienne, France.
Bruno PozzettoGIMAP-EA3064, Université de Lyon, Saint-Étienne, France.
Fabrice CognasseGIMAP-EA3064, Université de Lyon, Saint-Étienne, France; EFS Auvergne-Loire, Saint-Etienne, France.
Olivier GarraudGIMAP-EA3064, Université de Lyon, Saint-Étienne, France; EFS Auvergne-Loire, Saint-Etienne, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPlatelet component (PC) transfusion leads occasionally to inflammatory hazards. Certain BRMs that are secreted by the platelets themselves during storage may have some responsibility. METHODOLOGY/PRINCIPAL

findingsFirst, we identified non-stochastic arrangements of platelet-secreted BRMs in platelet components that led to acute transfusion reactions (ATRs). These data provide formal clinical evidence that platelets generate secretion profiles under both sterile activation and pathological conditions. We next aimed to predict the risk of hazardous outcomes by establishing statistical models based on the associations of BRMs within the incriminated platelet components and using decision trees. We investigated a large (n = 65) series of ATRs after platelet component transfusions reported through a very homogenous system at one university hospital. Herein, we used a combination of clinical observations, ex vivo and in vitro investigations, and mathematical modeling systems. We calculated the statistical association of a large variety (n = 17) of cytokines, chemokines, and physiologically likely factors with acute inflammatory potential in patients presenting with severe hazards. We then generated an accident prediction model that proved to be dependent on the level (amount) of a given cytokine-like platelet product within the indicated component, e.g., soluble CD40-ligand (>289.5 pg/109 platelets), or the presence of another secreted factor (IL-13, >0). We further modeled the risk of the patient presenting either a febrile non-hemolytic transfusion reaction or an atypical allergic transfusion reaction, depending on the amount of the chemokine MIP-1α (<20.4 or >20.4 pg/109 platelets, respectively). CONCLUSIONS/SIGNIFICANCE: This allows the modeling of a policy of risk prevention for severe inflammatory outcomes in PC transfusion.

Indexed as

Models, StatisticalAdultAgedBlood PlateletsCD40 LigandChemokine CCL3Computer SimulationCytokinesDecision TreesFemaleHumansInflammationInterleukin-13MaleMiddle AgedPlatelet TransfusionCCL3 protein, humanCD40 LigandChemokine CCL3CytokinesIL13 protein, humanInterleukin-13

Identifiers

PMID24830754
PMCPMC4022636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.